Indeed, MET interacts with several other receptor tyrosine kinases (RTKs) and MET heterodimers with EGFR, RON, HER2 and HER3 have been found abundant in MET-amplified cancer cells [39]. The gene discussed is ERBB2; the disease is cancer.